Algeta exercises option to co-promote Alpharadin in the United States

Conference call will be held today at 1pm CET, 12pm UK & 7am Eastern Oslo, Norway, 12 April 2012 – Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces that it has exercised its option to …
See all stories on this topic »